Severe Diarrhea Predominant Ibs In Women Therapeutics
1. Lotronex patent expiration
Treatment: For women with severe diarrhea-predominant irritable bowel syndrome (ibs)
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5360800 | LEGACY PHARMA | Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives |
Jan, 2013
(12 years ago) | |
| US6284770 | LEGACY PHARMA | Medicaments for the treatment of non-constipated female irritable bowel syndrome |
Oct, 2018
(7 years ago) | |
Drugs and Companies using ALOSETRON HYDROCHLORIDE ingredient
Market Authorisation Date: 09 February, 2000
Dosage: TABLET
How can I launch a generic of LOTRONEX before it's drug patent expiration?
More Information on Dosage
LOTRONEX family patents
